James Collins, Ph.D.
Broad Institute of MIT & Harvard and The Wyss Institute
James Collins, Ph.D., is the Termeer Professor of Medical Engineering & Science and professor of biological engineering at MIT, as well as a member of the Harvard-MIT Health Sciences & Technology Faculty. He is also a core founding faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University and an institute member of the Broad Institute of MIT and Harvard. He is a founder of the field of synthetic biology and his research group is currently focused on using synthetic biology to create next-generation diagnostics and therapeutics.
Collins' patented technologies have been licensed by over 25 biotechnology, pharma and medical devices companies, and he has co-founded a number of companies, including Synlogic, Senti Biosciences, Sherlock Biosciences and Cellarity, as well as Phare Bio, a non-profit focused on AI-driven antibiotic discovery. He has received numerous awards and honors, including a MacArthur "Genius" Award and the Dickson Prize in Medicine. He is an elected member of all 3 national academies—the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine.
Collins' patented technologies have been licensed by over 25 biotechnology, pharma and medical devices companies, and he has co-founded a number of companies, including Synlogic, Senti Biosciences, Sherlock Biosciences and Cellarity, as well as Phare Bio, a non-profit focused on AI-driven antibiotic discovery. He has received numerous awards and honors, including a MacArthur "Genius" Award and the Dickson Prize in Medicine. He is an elected member of all 3 national academies—the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine.